Skip to content

Trading of Oncopeptides AB (publ) on Nasdaq Stockholm commences today

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN.
Press releases

Oncopeptides AB (publ) (”Oncopeptides” or the ”Company”) hereby announces the outcome relating to the offering to acquire shares in the Company (the “Offering”) and the listing on Nasdaq Stockholm. The Offering attracted strong interest among Swedish and international investors and the Offering was oversubscribed several times.

For further information, please visit the Company webpage:

www.oncopeptides.se/en/trading-of-oncopeptides-ab-publ-on-nasdaq-stockholm-commences-today-ipo/